Gastric cancer: epidemiology, prevention, classification, and treatment

References

• WrightNAPoulsomRStampGTrefoil peptide gene expression in gastrointestinal epithelial cells in inflammatory bowel diseaseGastroenterology1993104112208419234
   PubMed Web of Science ®Google Scholar
• JemalABrayFCenterMMFerlayJWardEFormanDGlobal cancer statisticsCA Cancer J Clin2011612699021296855
   PubMed Web of Science ®Google Scholar
• StockMOttoFGene deregulation in gastric cancerGene2005360111916154715
   PubMed Web of Science ®Google Scholar
• ParkinDMBrayFFerlayJPisaniPGlobal cancer statistics 2002CA Cancer J Clin20055527410815761078
   PubMed Web of Science ®Google Scholar
• KanekoSYoshimuraTTime trend analysis of gastric cancer incidence in Japan by histological types, 1975–1989Br J Cancer200184340040511161407
   PubMed Web of Science ®Google Scholar
• BertuccioPChatenoudLLeviFRecent patterns in gastric cancer: a global overviewInt J Cancer2009125366667319382179
   PubMed Web of Science ®Google Scholar
• CamargoMCAndersonWFKingJBDivergent trends for gastric cancer incidence by anatomical subsite in US adultsGut201160121644164921613644
   PubMed Web of Science ®Google Scholar
• MunozNFranceschiSEpidemiology of gastric cancer and perspectives for preventionSalud Publica Mex19973943183309337564
   PubMed Web of Science ®Google Scholar
• BucklandGTravierNHuertaJMHealthy lifestyle index and risk of gastric adenocarcinoma in the EPIC cohort studyInt J Cancer2015137359860625557932
   PubMed Web of Science ®Google Scholar
• LinSHLiYHLeungKHuangCYWangXRSalt processed food and gastric cancer in a Chinese populationAsian Pac J Cancer Prev201415135293529825040991
   PubMedGoogle Scholar
• MassarratSStolteMDevelopment of gastric cancer and its preventionArch Iran Med201417751452024979566
   PubMed Web of Science ®Google Scholar
• NomuraAMHankinJHKolonelLNWilkensLRGoodmanMTStemmermannGNCase-control study of diet and other risk factors for gastric cancer in Hawaii (United States)Cancer Causes Control200314654755812948286
   PubMed Web of Science ®Google Scholar
• TavaniAMalerbaSPelucchiCDietary folates and cancer risk in a network of case-control studiesAnn Oncol201223102737274222898036
   PubMed Web of Science ®Google Scholar
• CamargoMCBurkRFBravoLEPlasma selenium measurements in subjects from areas with contrasting gastric cancer risks in ColombiaArch Med Res200839444345118375257
   PubMed Web of Science ®Google Scholar
• JenabMRiboliEFerrariPPlasma and dietary carotenoid, retinol and tocopherol levels and the risk of gastric adenocarcinomas in the European prospective investigation into cancer and nutritionBr J Cancer200695340641516832408
   PubMed Web of Science ®Google Scholar
• Ladeiras-LopesRPereiraAKNogueiraASmoking and gastric cancer: systematic review and meta-analysis of cohort studiesCancer Causes Control200819768970118293090
   PubMed Web of Science ®Google Scholar
• NishinoYInoueMTsujiIResearch Group for the Development and Evaluation of Cancer Prevention Strategies in JapanTobacco smoking and gastric cancer risk: an evaluation based on a systematic review of epidemiologic evidence among the Japanese populationJpn J Clin Oncol2006361280080717210611
   PubMed Web of Science ®Google Scholar
• JedrychowskiWWahrendorfJPopielaTRachtanJA case-control study of dietary factors and stomach cancer risk in PolandInt J Cancer19863768378423710615
   PubMed Web of Science ®Google Scholar
• LagergrenJBergströmRLindgrenANyrénOThe role of tobacco, snuff and alcohol use in the aetiology of cancer of the oesophagus and gastric cardiaInt J Cancer200085334034610652424
   PubMed Web of Science ®Google Scholar
• NagelGLinseisenJBoshuizenHCSocioeconomic position and the risk of gastric and oesophageal cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC-EURGAST)Int J Epidemiol2007361667617227779
   PubMedGoogle Scholar
• CoccoPPalliDBuiattiEOccupational exposures as risk factors for gastric cancer in ItalyCancer Causes Control1994532412488061172
   PubMed Web of Science ®Google Scholar
• SimpsonJRomanELawGPannettBWomen’s occupation and cancer: preliminary analysis of cancer registrations in England and Wales, 1971–1990Am J Ind Med199936117218510361604
   PubMed Web of Science ®Google Scholar
• AragonesNPollanMGustavssonPStomach cancer and occupation in Sweden: 1971–89Occup Environ Med200259532933711983848
   PubMed Web of Science ®Google Scholar
• WarrenJRMarshallBUnidentified curved bacilli on gastric epithelium in active chronic gastritisLancet198318336127312756134060
   PubMed Web of Science ®Google Scholar
• IARC Working Group on the Evaluation of Carcinogenic Risks to HumansLyon, 7–14 June 1994. Schistosomes, liver flukes and Helicobacter pyloriIARC Monogr Eval Carcinog Risks Hum19946112417715068
   PubMedGoogle Scholar
• FormanDNewellDGFullertonFAssociation between infection with Helicobacter pylori and risk of gastric cancer: evidence from a prospective investigationBMJ19913026788130213052059685
   PubMed Web of Science ®Google Scholar
• ParsonnetJSamloffIMNelsonLMOrentreichNVogelmanJHFriedmanGDHelicobacter pylori, pepsinogen, and risk for gastric adenocarcinomaCancer Epidemiol Biomarkers Prev1993254614668220091
   PubMed Web of Science ®Google Scholar
• SuerbaumSMichettiPHelicobacter pylori infectionN Engl J Med2002347151175118612374879
   PubMed Web of Science ®Google Scholar
• ParsonnetJFriedmanGDVandersteenDPHelicobacter pylori infection and the risk of gastric carcinomaN Engl J Med199132516112711311891020
   PubMed Web of Science ®Google Scholar
• GonzálezCAMegraudFBuissonniereAHelicobacter pylori infection assessed by ELISA and by immunoblot and noncardia gastric cancer risk in a prospective study: the Eurgast-EPIC projectAnn Oncol20122351320132421917738
   PubMed Web of Science ®Google Scholar
• MasudaGTokunagaAShirakawaTHelicobacter pylori infection, but not genetic polymorphism of CYP2E1, is highly prevalent in gastric cancer patients younger than 40 yearsGastric Cancer20071029810317577619
   PubMed Web of Science ®Google Scholar
• CorreaPHoughtonJCarcinogenesis of Helicobacter pyloriGastroenterology2007133265967217681184
   PubMed Web of Science ®Google Scholar
• RuggeMBusattoGCassaroMPatients younger than 40 years with gastric carcinoma: Helicobacter pylori genotype and associated gastritis phenotypeCancer199985122506251110375095
   PubMed Web of Science ®Google Scholar
• MalfertheinerPMegraudFO’MorainCCurrent concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus ReportGut200756677278117170018
   PubMed Web of Science ®Google Scholar
• ImaiSKoizumiSSugiuraMGastric carcinoma: monoclonal epithelial malignant cells expressing Epstein-Barr virus latent infection proteinProc Natl Acad Sci U S A19949119913191358090780
   PubMed Web of Science ®Google Scholar
• CzopekJPStojakMSińczakAEBV-positive gastric carcinomas in PolandPol J Pathol200354212312814575421
   PubMedGoogle Scholar
• TakadaKEpstein-Barr virus and gastric carcinomaMol Pathol200053525526111091849
   PubMedGoogle Scholar
• Zur HausenAvan ReesBPvan BeekJEpstein-Barr virus in gastric carcinomas and gastric stump carcinomas: a late event in gastric carcinogenesisJ Clin Pathol200457548749115113855
   PubMed Web of Science ®Google Scholar
• YamamotoNTokunagaMUemuraYEpstein-Barr virus and gastric remnant cancerCancer19947438058098039108
   PubMed Web of Science ®Google Scholar
• WangWHHuangJQZhengGFLamSKKarlbergJWongBCNon-steroidal anti-inflammatory drug use and the risk of gastric cancer: a systematic review and meta-analysisJ Natl Cancer Inst200395231784179114652240
   PubMedGoogle Scholar
• HarbisonSPDempseyDTPeptic ulcer diseaseCurr Probl Surg200542634645415988415
   PubMedGoogle Scholar
• FarrowDCVaughanTLHanstenPDUse of aspirin and other nonsteroidal anti-inflammatory drugs and risk of esophageal and gastric cancerCancer Epidemiol Biomarkers Prev199872971029488582
   PubMed Web of Science ®Google Scholar
• BombardierCLaineLReicinAVIGOR Study GroupComparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study GroupN Engl J Med2000343211520152811087881
   PubMed Web of Science ®Google Scholar
• La VecchiaCNegriEFranceschiSGentileAFamily history and the risk of stomach and colorectal cancerCancer199270150551606546
   PubMed Web of Science ®Google Scholar
• GuilfordPHopkinsJHarrawayJE-cadherin germline mutations in familial gastric cancerNature199839266744024059537325
   PubMed Web of Science ®Google Scholar
• SokoloffBPredisposition to cancer in the Bonaparte familyAm J Surg1938403673678
   Google Scholar
• VaughanTLDavisSKristalAThomasDBObesity, alcohol, and tobacco as risk factors for cancers of the esophagus and gastric cardia: adenocarcinoma versus squamous cell carcinomaCancer Epidemiol Biomarkers Prev19954285927742727
   PubMed Web of Science ®Google Scholar
• HsingAWHanssonLEMcLaughlinJKPernicious anemia and subsequent cancer. A population-based cohort studyCancer19937137457508431855
   PubMed Web of Science ®Google Scholar
• AirdIBentallHHRobertsJAA relationship between cancer of stomach and the ABO blood groupsBr Med J19531481479980113032504
   PubMed Web of Science ®Google Scholar
• OfferhausGJTersmetteACHuibregtseKMortality caused by stomach cancer after remote partial gastrectomy for benign conditions: 40 years of follow up of an Amsterdam cohort of 2633 postgastrectomy patientsGut19882911158815903209117
   PubMed Web of Science ®Google Scholar
• TashiroASanoMKinameriKFujitaKTakeuchiYComparing mass screening techniques for gastric cancer in JapanWorld J Gastroenterol200612304873487416937471
   PubMed Web of Science ®Google Scholar
• LeungWKWuMSKakugawaYScreening for gastric cancer in Asia: current evidence and practiceLancet Oncol20089327928718308253
   PubMed Web of Science ®Google Scholar
• DickenBJBigamDLCassCMackeyJRJoyAAHamiltonSMGastric adenocarcinoma: review and considerations for future directionsAnn Surg20052411273915621988
   PubMed Web of Science ®Google Scholar
• HirotaWKZuckermanMJAdlerDGStandards of Practice Committee, American Society for Gastrointestinal EndoscopyASGE guideline: the role of endoscopy in the surveillance of pre-malignant conditions of the upper GI tractGastrointest Endosc200663457058016564854
   PubMed Web of Science ®Google Scholar
• SkieruchaMMilneANOfferhausGJPolkowskiWPMaciejewskiRSitarzRMolecular alterations in gastric cancer with special reference to the early-onset subtypeWorld J Gastroenterol20162282460247426937134
   PubMed Web of Science ®Google Scholar
• KikuchiSNakajimaTNishiTAssociation between family history and gastric carcinoma among young adultsJpn J Cancer Res19968743323368641962
   PubMedGoogle Scholar
• FormanDBurleyVJGastric cancer: global pattern of the disease and an overview of environmental risk factorsBest Pract Res Clin Gastroenterol200620463364916997150
   PubMed Web of Science ®Google Scholar
• KokkolaASipponenPGastric carcinoma in young adultsHepatogastroenterology200148421552155511813570
   PubMedGoogle Scholar
• HaydenJDCawkwellLSue-LingHAssessment of microsatellite alterations in young patients with gastric adenocarcinomaCancer19977946846879024705
   PubMed Web of Science ®Google Scholar
• LimSLeeHSKimHSKimYIKimWHAlteration of E-cadherin-mediated adhesion protein is common, but microsatellite instability is uncommon in young age gastric cancersHistopathology200342212813612558744
   PubMed Web of Science ®Google Scholar
• Ramos-De la MedinaASalgado-NesmeNTorres-VillalobosGMedina-FrancoHClinicopathologic characteristics of gastric cancer in a young patient populationJ Gastrointest Surg20048324024415019915
   PubMed Web of Science ®Google Scholar
• MaetaMYamashiroHOkaATsujitaniSIkeguchiMKaibaraNGastric cancer in the young, with special reference to 14 pregnancy-associated cases: analysis based on 2,325 consecutive cases of gastric cancerJ Surg Oncol19955831911957898116
   PubMed Web of Science ®Google Scholar
• MilneANCarvalhoRMorsinkFMEarly-onset gastric cancers have a different molecular expression profile than conventional gastric cancersMod Pathol200619456457216474375
   PubMed Web of Science ®Google Scholar
• ThorbanSBöttcherKEtterMRoderJDBuschRSiewertJRPrognostic factors in gastric stump carcinomaAnn Surg2000231218819410674609
   PubMed Web of Science ®Google Scholar
• SonsHUBorchardFGastric carcinoma after surgical treatment for benign ulcer disease: some pathologic-anatomic aspectsInt Surg19877242222263448034
   PubMed Web of Science ®Google Scholar
• SinningCSchaeferNStandopJHirnerAWolffMGastric stump carcinoma – epidemiology and current concepts in pathogenesis and treatmentEur J Surg Oncol200733213313917071041
   PubMed Web of Science ®Google Scholar
• ToftgaardCGastric cancer after peptic ulcer surgery. A historic prospective cohort investigationAnn Surg198921021591642757419
   PubMed Web of Science ®Google Scholar
• TersmetteACGoodmanSNOfferhausGJMultivariate analysis of the risk of stomach cancer after ulcer surgery in an Amsterdam cohort of postgastrectomy patientsAm J Epidemiol1991134114211853856
   PubMed Web of Science ®Google Scholar
• van ReesBPCaspersEzur HausenADifferent pattern of allelic loss in Epstein-Barr virus-positive gastric cancer with emphasis on the p53 tumor suppressor pathwayAm J Pathol200216141207121312368194
   PubMed Web of Science ®Google Scholar
• BaasIOvan ReesBPMuslerAHelicobacter pylori and Epstein-Barr virus infection and the p53 tumour suppressor pathway in gastric stump cancer compared with carcinoma in the non-operated stomachJ Clin Pathol19985196626669930069
   PubMed Web of Science ®Google Scholar
• OfferhausGJvan de StadtJHuibregtseKTersmetteACTytgatGNThe mucosa of the gastric remnant harboring malignancy. Histologic findings in the biopsy specimens of 504 asymptomatic patients 15 to 46 years after partial gastrectomy with emphasis on nonmalignant lesionsCancer19896436987032743264
   PubMed Web of Science ®Google Scholar
• PalliDGalliMCaporasoNEFamily history and risk of stomach cancer in ItalyCancer Epidemiol Biomarkers Prev19943115188118379
   PubMed Web of Science ®Google Scholar
• LaurenPThe two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. An attempt at a histo-clinical classificationActa Pathol Microbiol Scand196564314914320675
   PubMedGoogle Scholar
• QiuMZCaiMYZhangDSClinicopathological characteristics and prognostic analysis of Lauren classification in gastric adenocarcinoma in ChinaJ Transl Med2013115823497313
   PubMed Web of Science ®Google Scholar
• AhnHSLeeHJHahnSEvaluation of the seventh American Joint Committee on Cancer/International Union Against Cancer Classification of gastric adenocarcinoma in comparison with the sixth classificationCancer2010116245592559820737569
   PubMed Web of Science ®Google Scholar
• LaurenPANevalainenTJEpidemiology of intestinal and diffuse types of gastric carcinoma. A time-trend study in Finland with comparison between studies from high- and low-risk areasCancer19937110292629338490820
   PubMed Web of Science ®Google Scholar
• RibeiroMMSarmentoJASobrinho SimõesMABastosJPrognostic significance of Lauren and Ming classifications and other pathologic parameters in gastric carcinomaCancer19814747807847226025
   PubMed Web of Science ®Google Scholar
• AmorosiABianchiSBuiattiECiprianiFPalliDZampiGGastric cancer in a high-risk area in Italy. Histopathologic patterns according to Lauren’s classificationCancer19886210219121963179931
   PubMed Web of Science ®Google Scholar
• SitarzRKocembaKMaciejewskiRPolkowskiPEffective cancer treatment by multidisciplinary teamsPol Przegl Chir201284737137622935461
   PubMedGoogle Scholar
• UshijimaTSasakoMFocus on gastric cancerCancer Cell20045212112514998488
   PubMed Web of Science ®Google Scholar
• KajitaniTThe general rules for the gastric cancer study in surgery and pathology. Part I. Clinical classificationJpn J Surg19811121271397300058
   PubMedGoogle Scholar
• Japanese Gastric Cancer AssociationJapanese gastric cancer treatment guidelines 2014 (ver. 4)Gastric Cancer2017201119
   Web of Science ®Google Scholar
• OnoHKondoHGotodaTEndoscopic mucosal resection for treatment of early gastric cancerGut200148222522911156645
   PubMed Web of Science ®Google Scholar
• GotodaTEndoscopic resection of early gastric cancerGastric Cancer200710111117334711
   PubMed Web of Science ®Google Scholar
• GotodaTYanagisawaASasakoMIncidence of lymph node metastasis from early gastric cancer: estimation with a large number of cases at two large centersGastric Cancer20003421922511984739
   PubMedGoogle Scholar
• OkinesAVerheijMAllumWGastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upAnn Oncol201021Suppl 5S50S54
   PubMedGoogle Scholar
• ScheidbachHLippertHMeyerFGastric carcinoma: when is palliative gastrectomy justified?Oncol Rev201042127132
   Google Scholar
• D’AngelicaMGonenMBrennanMFTurnbullADBainsMKarpehMSPatterns of initial recurrence in completely resected gastric adenocarcinomaAnn Surg2004240580881615492562
   PubMed Web of Science ®Google Scholar
• JanungerKGHafströmLNygrenPGlimeliusBSBU-groupSwedish Council of Technology Assessment in Health Care. A systematic overview of chemotherapy effects in gastric cancerActa Oncol2001402–330932611441938
   PubMed Web of Science ®Google Scholar
• EarleCCMarounJZurawLCancer Care Ontario Practice Guidelines Initiative Gastrointestinal Cancer Disease Site GroupNeoadjuvant or adjuvant therapy for resectable gastric cancer? A practice guidelineCan J Surg200245643844612500920
   PubMed Web of Science ®Google Scholar
• CunninghamDAllumWHStenningSPMAGIC Trial ParticipantsPerioperative chemotherapy versus surgery alone for resectable gastroesophageal cancerN Engl J Med20063551112016822992
   PubMed Web of Science ®Google Scholar
• PolkowskiWŁackoAGuzelZNowotwory żołądka [Gastric cancers]KrzakowskiMWarzechaKZalecenia postępowania diagnostyczno-terapeutycznego w nowotworach złośliwych – 2013 rok [Recommendations for Diagnostics and Treatment of Malignant Neoplasms – 2013]GdanskVia Medica2013119
   Google Scholar
• YchouMBoigeVPignonJPPerioperative chemotherapy compared with surgery alone for resectable gastroesophageal adenocarcinoma: an FNCLCC and FFCD multicenter phase III trialJ Clin Oncol201129131715172121444866
   PubMed Web of Science ®Google Scholar
• WaddellTVerheijMAllumWGastric cancer: ESMO-ESSO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-upAnn Oncol201324Suppl 6S57S63
   Google Scholar
• MacdonaldJSSmalleySRBenedettiJChemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junctionN Engl J Med20013451072573011547741
   PubMed Web of Science ®Google Scholar
• SmalleySRGundersonLTepperJGastric surgical adjuvant radiotherapy consensus report: rationale and treatment implementationInt J Radiat Oncol Biol Phys200252228329311872272
   PubMed Web of Science ®Google Scholar
• DikkenJLJansenEPCatsAImpact of the extent of surgery and postoperative chemoradiotherapy on recurrence patterns in gastric cancerJ Clin Oncol201028142430243620368551
   PubMed Web of Science ®Google Scholar
• Van CutsemEVan de VeldeCRothAEuropean Organisation for Research and Treatment of Cancer (EORTC)-gastrointestinal cancer groupExpert opinion on management of gastric and gastro-oesophageal junction adenocarcinoma on behalf of the European Organisation for Research and Treatment of Cancer (EORTC)-gastrointestinal cancer groupEur J Cancer200844218219418093827
   PubMed Web of Science ®Google Scholar
• WilkeHStahlMTherapie beim Magenkarzinom. Aus onkologischer Sicht [Therapy in gastric cancer. From an oncological perspective]Chirurg2009801110231027 German19902288
   PubMed Web of Science ®Google Scholar
• OttKLordickFNeoadjuvant therapy in the upper gastrointestinal tract. Gastric cancer from a surgical viewpointChirurg2009801110281034 German19756431
   PubMed Web of Science ®Google Scholar
• WagnerADUnverzagtSGrotheWChemotherapy for advanced gastric cancerCochrane Database Syst Rev20103CD004064
   PubMed Web of Science ®Google Scholar
• DankMZaluskiJBaroneCRandomized phase III study comparing irinotecan combined with 5-fluorouracil and folinic acid to cisplatin combined with 5-fluorouracil in chemotherapy naive patients with advanced adenocarcinoma of the stomach or esophagogastric junctionAnn Oncol20081981450145718558665
   PubMed Web of Science ®Google Scholar
• Thuss-PatiencePCKretzschmarABichevDSurvival advantage for irinotecan versus best supportive care as second-line chemotherapy in gastric cancer a randomised phase III study of the Arbeitsgemein-schaft Internistische Onkologie (AIO)Eur J Cancer201147152306231421742485
   PubMed Web of Science ®Google Scholar
• KangJHLeeSILimDHSalvage chemotherapy for pretreated gastric cancer: a randomized phase III trial comparing chemotherapy plus best supportive care with best supportive care aloneJ Clin Oncol201230131513151822412140
   PubMed Web of Science ®Google Scholar
• FordHEMarshallABridgewaterJADocetaxel versus active symptom control for refractory oesophagogastric adenocarcinoma (COUGAR-02): an open-label, phase 3 randomised controlled trialLancet Oncol2014151788624332238
   PubMed Web of Science ®Google Scholar
• RoyACParkSRCunninghamDA randomized phase II study of PEP02 (MM-398), irinotecan or docetaxel as a second-line therapy in patients with locally advanced or metastatic gastric or gastro-oesophageal junction adenocarcinomaAnn Oncol20132461567157323406728
   PubMed Web of Science ®Google Scholar
• MatzingerOGerberEBernsteinZEORTC-ROG expert opinion: radiotherapy volume and treatment guidelines for neoadjuvant radiation of adenocarcinomas of the gastroesophageal junction and the stomachRadiother Oncol200992216417519375186
   PubMed Web of Science ®Google Scholar
• TeyJBackMFShakespeareTPThe role of palliative radiation therapy in symptomatic locally advanced gastric cancerInt J Radiat Oncol Biol Phys200767238538817118569
   PubMed Web of Science ®Google Scholar
• AsakuraHHashimotoTHaradaHPalliative radiotherapy for bleeding from advanced gastric cancer: is a schedule of 30 Gy in 10 fractions adequate?J Cancer Res Clin Oncol2011137112513020336314
   PubMed Web of Science ®Google Scholar
• BangYJVan CutsemEFeyereislovaAToGA Trial InvestigatorsTrastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trialLancet2010376974268769720728210
   PubMed Web of Science ®Google Scholar
• WilkeHMuroKVan CutsemERamucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): a double-blind, randomised phase 3 trialLancet Oncol201415111224123525240821
   PubMed Web of Science ®Google Scholar
• FuchsCSTomasekJYongCJREGARD Trial InvestigatorsRamucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trialLancet20143839911313924094768
   PubMed Web of Science ®Google Scholar
• YangXJHuangCQSuoTCytoreductive surgery and hyperthermic intraperitoneal chemotherapy improves survival of patients with peritoneal carcinomatosis from gastric cancer: final results of a phase III randomized clinical trialAnn Surg Oncol20111861575158121431408
   PubMed Web of Science ®Google Scholar
• GlehenOGillyFNArvieuxCPeritoneal carcinomatosis from gastric cancer: a multi-institutional study of 159 patients treated by cytoreductive surgery combined with perioperative intraperitoneal chemotherapyAnn Surg Oncol20101792370237720336386
   PubMed Web of Science ®Google Scholar